Kato Takao, Pezzella Francesco, Steers Graham, Campo Leticia, Leek Russell D, Turley Helen, Kameoka Shingo, Nishikawa Toshio, Harris Adrian L, Gatter Kevin C, Fox Stephen
Department of Surgery II, School of Medicine, Tokyo Women's Medical University 8-1 Kawadacho, Shinjuku-ku, Tokyo 162-8666, Japan ; Cancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Cancer Research UK, Tumor Pathology Group, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital Headington, Oxford, OX3 9DU, UK.
Int J Clin Exp Pathol. 2014 Oct 15;7(11):7967-78. eCollection 2014.
This study was undertaken to investigate the associations of blood vessel invasion (BVI), lymphatic vessel invasion (LVI) or other variables and long-term survival in 173 Japanese and 184 British patients with primary invasive breast cancer, and whether they are associated with survival differences between Japanese and British patients. BVI was detected by objective methods, using both factor VIII-related antigen (F-VIII) staining and elastica van Gieson (E v G) staining. BVI was classified into three subtypes. 1) BVI e, BVI detected by E v G staining alone, 2) BVI f, BVI detected by F-VIII staining alone, 3) BVIef, BVI evaluated by combining BVIf and BVIe. LVI was also detected by objective methods, using lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1) staining alone. There was a borderline significance between the frequencies for BVIef of British patients and those of Japanese patients (8.2% vs 3.5%; P = 0.06) but not for LVI (P = 0.36). British patients had a significantly worse relapse-free survival (RFS) and overall survival (OS) than Japanese patients (P < 0.01, P < 0.01, respectively) even though their tumors were smaller and more ER-positive with a similar prevalence of lymph-node involvement. LVI was not significantly associated with RFS and OS, however, BVIef positive tumors had a significantly worse RFS and OS compared with BVIef negative patients, after statistical adjustment for the other variables (P = 0.02, P = 0.01, respectively). The present study shows that BVIef variability might contribute to the Japanese and British disparities in breast cancer outcomes.
本研究旨在调查173名日本原发性浸润性乳腺癌患者和184名英国原发性浸润性乳腺癌患者的血管侵犯(BVI)、淋巴管侵犯(LVI)或其他变量与长期生存之间的关联,以及它们是否与日本和英国患者之间的生存差异相关。通过客观方法检测BVI,同时使用因子VIII相关抗原(F-VIII)染色和弹性纤维染色(E v G)。BVI分为三种亚型。1)BVI e,仅通过E v G染色检测到的BVI;2)BVI f,仅通过F-VIII染色检测到的BVI;3)BVIef,通过结合BVIf和BVIe评估的BVI。LVI也通过客观方法检测,仅使用淋巴管内皮透明质酸受体-1(LYVE-1)染色。英国患者和日本患者的BVIef频率之间存在临界显著性差异(8.2%对3.5%;P = 0.06),但LVI频率之间无差异(P = 0.36)。尽管英国患者的肿瘤较小且雌激素受体阳性率更高,淋巴结受累患病率相似,但他们的无复发生存期(RFS)和总生存期(OS)明显比日本患者差(分别为P < 0.01,P < 0.01)。LVI与RFS和OS无显著关联,然而,在对其他变量进行统计调整后,BVIef阳性肿瘤患者的RFS和OS明显比BVIef阴性患者差(分别为P = 0.02,P = 0.01)。本研究表明,BVIef的变异性可能导致日本和英国乳腺癌患者预后的差异。